Smoking Cessation Drug May Boost Cognition in Schizophrenia

By |2021-11-11T17:14:20-08:00March 22nd, 2017|Brief Bulletins from the Field, We Know Psychiatry|

In findings reported in a letter to the editor published online March 10 in Schizophrenia Research and reported by Medscape Medical News, the smoking cessation drug varenicline (Chantix) appears to enhance cognition in nonsmoking individuals with and those without schizophrenia. The results also showed that the drug reduced the cognitive [...]